靶向 CCR5 的同种异体 γδ CD19 CAR-T 细胞用于 HIV 相关 B 细胞恶性肿瘤免疫治疗
CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy.
肿瘤细胞治疗研究
FRONTIER PAPERS
近 5 年肿瘤细胞治疗领域的研究论文。默认按评分排序(权威性 + 新鲜度)。
CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy.
Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers.
Enrichment of innate immune cells from PBMC followed by triple cytokine activation for adoptive immunotherapy.
Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells.
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。